Trials / Completed
CompletedNCT06040060
Ketamine Effects as Preemptive Analgesia
Effects of Ketamine 0.5 Mg/Kgbw Administration as Preemptive Analgesia on Analgesia Duration and the Need for Fentanyl Following Hysterectomy Surgery
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Universitas Padjadjaran · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this randomized controlled trial is to compare the effect of preemptive ketamine administration to placebo administration in patients underwent hysterectomy surgery. The main questions it aims to answer are: 1. To determine the effect of ketamine at a dose of 0.5 mg/kgBW as preemptive analgesia on the duration of analgesia after hysterectomy surgery 2. To determine the effect of ketamine at a dose of 0.5 mg/kgBW as preemptive analgesia on the need for fentanyl after hysterectomy surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | The intervention was prepared by the research team (anesthesia resident) in the form of ketamine which had been diluted to a dosage of 10 mg/cc, taken according to the required dose based on actual body weight then diluted with 0.9% NaCl to 10 cc. Then the two solutions were given to researchers without knowing the contents of the drugs that had been prepared by the resident who assisted in this research. |
| OTHER | Placebo | While the 0.9% NaCl solution was used as placebo was prepared in a 10 cc syringe |
Timeline
- Start date
- 2022-12-27
- Primary completion
- 2023-03-03
- Completion
- 2023-03-03
- First posted
- 2023-09-15
- Last updated
- 2023-09-22
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT06040060. Inclusion in this directory is not an endorsement.